Our initial hypothesis was that PDK4−/− animals would exhibit reduced tumor formation and be more responsive to cisplatin based on prior in vitro data in BCa, in addition to numerous studies demonstrating an antitumorigenic effect of PDK inhibition [7,20,24,34]. Here, PDK4 is linked to neoplasm.